Combination therapy for type II (non-insulin-dependent) diabetes mellitus with insulin and sulfonylureas has been a topic of interest since the latter were introduced to clinical use. In recent years, improved understanding of potential complications associated with hyperinsulinemia has led to resurgent interest in alternatives to insulin monotherapy for patients who have failed on a regimen of diet and sulfonylureas. A plethora of clinical trials have reported on the efficacy of oral hypoglycemic agents in limiting insulin requirements while achieving glycemic control in this subset of diabetic patients. However, few studies have been appropriate in both design and duration to provide convincing results. The randomized placebo-controlled double-blind trials that have used a parallel design and study periods of up to 1 yr have uniformly investigated second-generation sulfonylureas and yielded the most reliable information. In all instances, the combination regimen achieved reduction in insulin requirement with varying evidence of a pancreatic effect as the responsible mechanism. This treatment modality is becoming more widely accepted in the effort to achieve optimal glycemic control with minimum risk to the patient.
Skip Nav Destination
Article navigation
Original Articles|
June 01 1990
Combination Therapy With Insulin and Sulfonylureas for Type II Diabetes
Timothy S Bailey, MD;
Timothy S Bailey, MD
Department of Medicine, Division of Endocrinology, State University of New York Health Science Center at Brooklyn; and the Division of Endocrinology, Diabetes, and Nutrition, St. Luke's/Roosevelt Hospital Center
New York, New York
Search for other works by this author on:
Nicholas H E Mezitis, MD
Nicholas H E Mezitis, MD
Department of Medicine, Division of Endocrinology, State University of New York Health Science Center at Brooklyn; and the Division of Endocrinology, Diabetes, and Nutrition, St. Luke's/Roosevelt Hospital Center
New York, New York
Search for other works by this author on:
Address correspondence and reprint requests to Nicholas H.E. Mezitis, MD, Division of Endocrinology, Diabetes, and Nutrition, St. Luke's/Roosevelt Hospital Center, 114th Street and Amsterdam Avenue, New York, NY 10025.
Citation
Timothy S Bailey, Nicholas H E Mezitis; Combination Therapy With Insulin and Sulfonylureas for Type II Diabetes. Diabetes Care 1 June 1990; 13 (6): 687–695. https://doi.org/10.2337/diacare.13.6.687
Download citation file: